Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-227555
Filing Date
2025-10-02
Accepted
2025-10-02 08:58:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d68864d424b3.htm 424B3 22687
2 GRAPHIC g68864g1002015656008.jpg GRAPHIC 3210
  Complete submission text file 0001193125-25-227555.txt   28543
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 251367121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)